Eddie Hu

1.3k total citations
23 papers, 1.1k citations indexed

About

Eddie Hu is a scholar working on Oncology, Pathology and Forensic Medicine and Genetics. According to data from OpenAlex, Eddie Hu has authored 23 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 7 papers in Pathology and Forensic Medicine and 6 papers in Genetics. Recurrent topics in Eddie Hu's work include Cancer Treatment and Pharmacology (6 papers), Lymphoma Diagnosis and Treatment (6 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Eddie Hu is often cited by papers focused on Cancer Treatment and Pharmacology (6 papers), Lymphoma Diagnosis and Treatment (6 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Eddie Hu collaborates with scholars based in United States and India. Eddie Hu's co-authors include Lawrence M. Weiss, Roger A. Warnke, Jeffrey Sklar, Courtney Moulds, Michael L. Cleary, Gary S. Wood, John G. Strickler, Gary S. Wood, Richard T. Hoppe and Russell K. Brynes and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Oncology.

In The Last Decade

Eddie Hu

23 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eddie Hu United States	13	546	383	336	273	222	23	1.1k
N T O'Connor United Kingdom	15	549 1.0×	302 0.8×	370 1.1×	204 0.7×	336 1.5×	23	1.1k
Cinzia Pellegrini Italy	20	1.1k 2.0×	519 1.4×	317 0.9×	295 1.1×	294 1.3×	85	1.4k
Martin‐Leo Hansmann Germany	18	819 1.5×	530 1.4×	352 1.0×	156 0.6×	258 1.2×	27	1.3k
Grete F. Lauritzsen Norway	19	851 1.6×	692 1.8×	623 1.9×	174 0.6×	228 1.0×	34	1.4k
Shashikant Chittal France	21	828 1.5×	740 1.9×	240 0.7×	127 0.5×	313 1.4×	36	1.3k
MF Martelli Italy	15	544 1.0×	376 1.0×	506 1.5×	105 0.4×	214 1.0×	30	1.2k
James T. Sundeen United States	12	554 1.0×	330 0.9×	240 0.7×	65 0.2×	246 1.1×	15	804
P Solal-Céligny France	8	1.1k 1.9×	743 1.9×	215 0.6×	94 0.3×	378 1.7×	13	1.3k
J. Zeffren United States	14	247 0.5×	325 0.8×	304 0.9×	177 0.6×	101 0.5×	18	772
J. M. Vose United States	15	801 1.5×	596 1.6×	148 0.4×	52 0.2×	289 1.3×	34	1.2k

Countries citing papers authored by Eddie Hu

Since Specialization

Citations

This map shows the geographic impact of Eddie Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eddie Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eddie Hu more than expected).

Fields of papers citing papers by Eddie Hu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eddie Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eddie Hu. The network helps show where Eddie Hu may publish in the future.

Co-authorship network of co-authors of Eddie Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Eddie Hu. A scholar is included among the top collaborators of Eddie Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eddie Hu. Eddie Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Peddi, Parvin F., Merry Tetef, Paul Coluzzi, et al.. (2020). Phase II randomized trial of a non-steroidal mouth wash for prevention and treatment of stomatitis in women with hormone receptor positive breast cancer treated with everolimus. Therapeutic Advances in Medical Oncology. 12. 3863582299–3863582299. 1 indexed citations

2.

Keung, Yi‐Kong, Tina Wang, & Eddie Hu. (2019). Acute myeloid leukemia with complex cytogenetic abnormalities associated with long-term use of oral colloidal silver as nutritional supplement – Case report and review of literature. Journal of Oncology Pharmacy Practice. 26(1). 212–215. 3 indexed citations

3.

Hurvitz, Sara A., Julie Taguchi, David W. Chan, et al.. (2018). Phase Ib/II single-arm trial evaluating the combination of everolimus, lapatinib and capecitabine for the treatment of HER2-positive breast cancer with brain metastases (TRIO-US B-09). Therapeutic Advances in Medical Oncology. 10. 3861422379–3861422379. 25 indexed citations

4.

Keung, Yi‐Kong, et al.. (2015). A case of recurrent pancytopenia in a patient with acute promyelocytic leukemia on maintenance chemotherapy and concomitant methyltetrahydrofolate reductase and thiopurine S-methyltransferase mutation - review of literature. Journal of Oncology Pharmacy Practice. 22(3). 548–551. 1 indexed citations

5.

Garon, Edward B., Jill M. Siegfried, Steven M. Dubinett, et al.. (2013). Abstract 4664: Result of TORI L-03, a randomized, multicenter phase II clinical trial of erlotinib (E) or E + fulvestrant (F) in previously treated advanced non-small cell lung cancer (NSCLC).. Cancer Research. 73(8_Supplement). 4664–4664. 7 indexed citations

6.

Keung, Yi‐Kong, et al.. (2012). Higher prevalence of BRCA2 mutations among Chinese breast cancer patients in a community oncology clinic.. Journal of Clinical Oncology. 30(15_suppl). e12017–e12017. 1 indexed citations

7.

Hurvitz, Sara A., Heather Allen, Rebecca Moroose, et al.. (2010). A Phase II Trial of Docetaxel With Bevacizumab as First-line Therapy for HER2-Negative Metastatic Breast Cancer (TORI B01). Clinical Breast Cancer. 10(4). 307–312. 7 indexed citations

8.

Berlin, Jordan, James Posey, Simon Tchekmedyian, et al.. (2009). Panitumumab with Irinotecan/Leucovorin/5-Fluorouracil for First-Line Treatment of Metastatic Colorectal Cancer. Clinical Colorectal Cancer. 8. 9–14. 1 indexed citations

9.

Hurvitz, Sara A., Heather Allen, R Moroose, et al.. (2008). Final results of a phase II study of bevacizumab plus docetaxel for the first-line treatment of metastatic breast cancer (TORI-B01). European Journal of Cancer Supplements. 6(7). 217–217. 1 indexed citations

10.

Berlin, Jordan, James Posey, Simon Tchekmedyian, et al.. (2007). Panitumumab with Irinotecan/Leucovorin/5-Fluorouracil for First-Line Treatment of Metastatic Colorectal Cancer. Clinical Colorectal Cancer. 6(6). 427–432. 79 indexed citations

11.

Berlin, Jordan, James Posey, Simon Tchekmedyian, et al.. (2007). Panitumumab with Irinotecan/Leucovorin/5-Fluorouracil for First-Line Treatment of Metastatic Colorectal Cancer. 1(1). 50–55. 12 indexed citations

12.

Zimmer, Aline, Edward A. Silverstein, Stewart Spies, et al.. (1993). A Phase I Escalating-Dose Safety, Dosimetry and Efficacy Study of Radiolabeled Monoclonal Antibody LYM-1. PubMed. 8(1). 3–16. 26 indexed citations

13.

Shibata, Darryl, Eddie Hu, Lawrence M. Weiss, Russell K. Brynes, & Bharat N. Nathwani. (1990). Detection of specific t(14;18) chromosomal translocations in fixed tissues. Human Pathology. 21(2). 199–203. 56 indexed citations

14.

Hu, Eddie, Richard H. Ko, Robert T. Koda, et al.. (1990). Phase I toxicity and pharmacology study of trimethylcolchicinic acid in patients with advanced malignancies. Cancer Chemotherapy and Pharmacology. 26(5). 359–364. 9 indexed citations

15.

Ellison, Douglas J., et al.. (1990). Immunogenetic analysis of bone marrow aspirates in patients with non‐hodgkin lymphomas. American Journal of Hematology. 33(3). 160–166. 4 indexed citations

16.

Weiss, Lawrence M., et al.. (1989). Detection of Clonal T-Cell Receptor Gene Rearrangements in the Peripheral Blood of Patients with Mycosis Fungoides/Sezary Syndrome. Journal of Investigative Dermatology. 92(4). 601–604. 82 indexed citations

17.

Hu, Eddie, Alan L. Epstein, Gregory S. Naeve, et al.. (1989). A phase 1a clinical trial of LYM‐1 monoclonal antibody serotherapy in patients with refractory b cell malignancies. Hematological Oncology. 7(2). 155–166. 68 indexed citations

18.

Hu, Eddie, et al.. (1986). Chemotherapy of malignant thymoma. Case report and review of the literature. Cancer. 57(6). 1101–1104. 73 indexed citations

19.

Grody, Wayne W., Lawrence M. Weiss, Roger A. Warnke, et al.. (1985). Gastrointestinal lymphomas. The American Journal of Surgical Pathology. 9(5). 328–337. 51 indexed citations

20.

Hu, Eddie, James D. Thompson, Sandra J. Horning, et al.. (1985). DETECTION OF B-CELL LYMPHOMA IN PERIPHERAL BLOOD BY DNA HYBRIDISATION. The Lancet. 326(8464). 1092–1095. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact